US 12186375
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
granted A61KA61K38/37A61K47/60
Quick answer
US patent 12186375 (Factor VIII chimeric and hybrid polypeptides, and methods of use thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/37, A61K47/60, A61K47/68, A61P